| Risk factor for AIN2+ | OR | (95% CI) | |
| anal HPV | Oncogenic | 7.4 | (1.3-37) |
| Non-oncogenic | 2.2 | (0.42-11) | |
| Both HPV types | 10 | (2-50) | |
| Cervix HPV oncogenic | 1.8 | (0.57-5.9) | |
| h/o anal intercourse | 1.2 | (0.64-2.4) | |
| Risk factor for AIN2+ | OR | (95% CI) | |
| anal HPV | Oncogenic | 7.4 | (1.3-37) |
| Non-oncogenic | 2.2 | (0.42-11) | |
| Both HPV types | 10 | (2-50) | |
| Cervix HPV oncogenic | 1.8 | (0.57-5.9) | |
| h/o anal intercourse | 1.2 | (0.64-2.4) | |